strensİq 40 mg/1.0 ml enjeksİyonluk çözeltİ, 12 adet
alexİon İlaÇ tİc. ltd. Ştİ. - asfotase alfa -
strensİq 80 mg/0.8 ml enjeksİyonluk çözeltİ, 12 adet
alexİon İlaÇ tİc. ltd. Ştİ. - asfotase alfa -
soliris 300 mg/30 ml konsantre İnfüzyon çözeltİsİ
alexİon İlaÇ tİc. ltd. Ştİ. - ekulizumab -
kanuma 2 mg/ml İnfüzyonluk çözeltİ hazirlamak İçİn konsantre, 1 adet
alexİon İlaÇ tİc. ltd. Ştİ. - sebelipaz alfa -
kanuma 2 mg/ml konzentrat zur herstellung einer infusionslösung
alexion pharma gmbh - sebelipasum alfa - konzentrat zur herstellung einer infusionslösung - sebelipasum alfa 2 mg, trinatrii citras dihydricus corresp. natrium 3.2 mg, acidum citricum monohydricum, albuminum seri humani, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - langfristige enzymersatztherapie bei patienten aller altersgruppen mit lal-mangel - biotechnologika
hlal rdna construct in sbc lal-c chickens- hlal rdna construct in sbc lal-c chicken not applicable
alexion pharmaceuticals, inc. - hlal rdna construct in sbc lal-c chicken (unii: mg6au4c2hb) (hlal rdna construct in sbc lal-c chicken - unii:mg6au4c2hb) - hlal rdna construct in sbc lal-c chicken 1 [arb'u] in 1 [arb'u] - the sbc lal-c lineage must be housed in only those alexion pharmaceutical, inc. facilities specified in the approved application.
soliris solution
alexion pharma gmbh - Éculizumab - solution - 10mg - Éculizumab 10mg - complement inhibitors
strensiq solution
alexion pharma gmbh - asfotase alfa - solution - 40mg - asfotase alfa 40mg - enzymes
strensiq solution
alexion pharma gmbh - asfotase alfa - solution - 40mg - asfotase alfa 40mg - enzymes
strensiq solution
alexion pharma gmbh - asfotase alfa - solution - 40mg - asfotase alfa 40mg - enzymes